STOCK TITAN

Regeneron Announces Investor Conference Presentations

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Regeneron (NASDAQ: REGN) will webcast management presentations at two investor conferences in May and June 2026. Sessions are scheduled for BofA Securities Health Care Conference on May 12, 2026 at 10:00 a.m. PT (1:00 p.m. ET) and Goldman Sachs Global Healthcare on June 8, 2026 at 2:00 p.m. ET.

Webcasts, replays, and transcripts will be available via the company's Investors & Media page and archived for at least 30 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – REGN

-0.27%
1 alert
-0.27% News Effect

On the day this news was published, REGN declined 0.27%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TARRYTOWN, N.Y., April 20, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• BofA Securities Health Care Conference 2026 at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 12, 2026

• Goldman Sachs 47th Annual Global Healthcare Conference at 2:00 p.m. ET on Monday,  June 8, 2026

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier
of medicine with data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com        


FAQ

When will Regeneron (REGN) present at the BofA Securities Health Care Conference 2026?

Regeneron will present on May 12, 2026 at 10:00 a.m. PT (1:00 p.m. ET). According to the company, the session will be webcast and accessible from the Investors & Media page with replays archived for at least 30 days.

What is the schedule for Regeneron (REGN) at the Goldman Sachs 47th Annual Global Healthcare Conference?

Regeneron is scheduled to present on June 8, 2026 at 2:00 p.m. ET. According to the company, the presentation will be webcast, and replays and transcripts will be available on the Investors & Media page for at least 30 days.

How can investors access Regeneron (REGN) conference webcasts and replays?

Investors can access live webcasts and replays via Regeneron's Investors & Media page at the company's website. According to the company, replays and transcripts will be archived there for a minimum of 30 days.

Will Regeneron (REGN) provide transcripts of the investor conference presentations?

Yes. According to the company, transcripts of the webcasts will be posted on the Investors & Media page and archived alongside replays for at least 30 days following each presentation.

Are the Regeneron (REGN) conference webcasts available live and on demand?

Yes. According to the company, each session will be webcast live and then made available on demand as replays on the Investors & Media page, with transcripts archived for at least 30 days.

Which web page hosts Regeneron's (REGN) investor event webcasts for May and June 2026?

Regeneron's investor event webcasts are hosted on the Investors & Media page at https://investor.regeneron.com/events-and-presentations. According to the company, replays and transcripts will remain archived there for at least 30 days.